RecruitingNCT05734378

Prognosis of Cerebral Small Vessel Disease

Prognosis of Cerebral Small Vessel Disease - a Prospective Cohort Study (PRO-SVD)

Sponsor

Insel Gruppe AG, University Hospital Bern

Enrollment

900 participants

Start Date

Dec 1, 2020

Study Type

OBSERVATIONAL

Conditions

Cerebral Amyloid Angiopathy Cadasil Small Vessel Cerebrovascular Disease CAA - Cerebral Amyloid Angiopathy

Summary

Prognosis of small vessel disease (SVD) depends on the underlying type of SVD and index manifestation. The aim of this prospective, observational cohort study is to determine the risk of different outcome events among patients with SVD according to the type of index presentation.

Eligibility

Min Age: 16 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a new treatment for people with caa - cerebral amyloid angiopathy, cadasil, and other related conditions. The study is currently recruiting participants at 1 location.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.